Chronic Δ-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions

This publication has 20 references indexed in Scilit:

• Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor
  European Journal of Pharmacology, 1999
• Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice
  Published by Elsevier ,1999
• Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Δ‐9‐tetrahydrocannabinol
  British Journal of Pharmacology, 1998
• Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Augments cAMP Accumulation in Striatal Neurons: Evidence for a G_sLinkage to the CB1 Receptor
  Journal of Neuroscience, 1997
• Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by Δ9-tetrahydrocannabinol (Δ9-THC): A putative mechanism of cannabinoid-induced immune modulation
  Biochemical Pharmacology, 1997
• Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat
  European Journal of Pharmacology, 1996
• Development of behavioral tolerance to Δ9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain
  Pharmacology Biochemistry and Behavior, 1993
• Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study
  Brain Research, 1993
• Cannabinoid Receptors and Modulation of Cyclic AMP Accumulation in the Rat Brain
  Journal of Neurochemistry, 1990
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976